Filing Details
- Accession Number:
- 0001567619-22-013886
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-11 19:46:22
- Reporting Period:
- 2022-07-08
- Accepted Time:
- 2022-07-11 19:46:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1380710 | Eric George Davis | C/O Biomarin Pharmaceutical Inc. 770 Lindaro St. San Rafael CA 94901 | Evp, Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-07-08 | 7,398 | $90.00 | 58,941 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Trade made pursuant to a 10b5-1 plan executed on March 4, 2022.